Clinical Trial Update: Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing lidocaine analgesia with extended-release oxycodone for neuropathic pain in multiple sclerosis was terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Neuropathic Pain
• Pain

Drugs mentioned

• Lidocaine (Lidocaine)
• Oxycodone extended-release (oxycodone)

Snippet

Sponsor: University of Rochester | Conditions: Neuropathic Pain, Chronic Pain | Phase 4 | Status: TERMINATED | Results posted: 2015-07-17